المؤلفون: Yamamoto K; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Tanabe Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan. ytanabe@toranomon.gr.jp., Nonogaki K; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Watanabe S; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Takemura K; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Yamanaka T; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Kizawa R; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Yamaguchi T; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Suyama K; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Hayashi N; Department of Dermatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan., Miura Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Sep 10; Vol. 32 (10), pp. 647. Date of Electronic Publication: 2024 Sep 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Taxoids*/adverse effects , Taxoids*/therapeutic use , Nail Diseases*/chemically induced , Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/therapeutic use, Humans ; Japan ; Surveys and Questionnaires ; Female ; Male ; Neoplasms/drug therapy ; Quality of Life ; Health Personnel/statistics & numerical data ; Middle Aged

المؤلفون: Mohanan S; Global Innovative Centre for Advanced Nanomaterials, College of Engineering, Science and Environment, The University of Newcastle, Callaghan, 2308, Australia., Sathish CI; Global Innovative Centre for Advanced Nanomaterials, College of Engineering, Science and Environment, The University of Newcastle, Callaghan, 2308, Australia., Ramadass K; Global Innovative Centre for Advanced Nanomaterials, College of Engineering, Science and Environment, The University of Newcastle, Callaghan, 2308, Australia., Liang M; School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, 2308, Australia., Vinu A; Global Innovative Centre for Advanced Nanomaterials, College of Engineering, Science and Environment, The University of Newcastle, Callaghan, 2308, Australia.

المصدر: Small (Weinheim an der Bergstrasse, Germany) [Small] 2024 Sep; Vol. 20 (39), pp. e2303269. Date of Electronic Publication: 2023 Jun 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101235338 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-6829 (Electronic) Linking ISSN: 16136810 NLM ISO Abbreviation: Small Subsets: MEDLINE

مواضيع طبية MeSH: Silicon Dioxide*/chemistry , Nanoparticles*/chemistry , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/pathology , Taxoids*/pharmacology , Taxoids*/chemistry, Humans ; Male ; Porosity ; Cell Line, Tumor ; Particle Size ; PC-3 Cells ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemistry ; Drug Delivery Systems ; Cell Survival/drug effects ; Drug Carriers/chemistry

المؤلفون: Carolina Cruz de Sousa A; Department of Pharmacy, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza - CE, Brazil., da Silva Santos E; Department of Pharmacy, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza - CE, Brazil., da Silva Moreira T; Department of Pharmacy, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza - CE, Brazil., Gabriela Araújo Mendes M; Department of Pharmacy, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza - CE, Brazil., Rodrigues Arruda B; Drug Research and Development Center, Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceara, Fortaleza, Brazil., de Jesus Guimarães C; Drug Research and Development Center, Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceara, Fortaleza, Brazil; Pharmacy Sector, Oncology Control Foundation of the State of Amazonas (FCECON), Manaus, AM, Brazil., de Brito Vieira Neto J; Drug Research and Development Center, Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceara, Fortaleza, Brazil., Santiago de Oliveira Y; Institute of Health Sciences, University of International Integration of the Afro-Brazilian Lusophony - UNILAB, Redenção - CE, Brazil., Pedro Ayala A; Department of Physics, Federal University of Ceará, Fortaleza, Ceará, Brazil., Rodrigues da Costa MD; Department of Clinical and Toxicological Analyzes, Federal University of Ceará, Fortaleza, Brazil., Lima Sampaio T; Department of Clinical and Toxicological Analyzes, Federal University of Ceará, Fortaleza, Brazil., Paula Negreiros Nunes Alves A; Dental Clinic Department, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, Ceará, Brazil., Pessoa C; Drug Research and Development Center, Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceara, Fortaleza, Brazil., Petrilli R; Institute of Health Sciences, University of International Integration of the Afro-Brazilian Lusophony - UNILAB, Redenção - CE, Brazil., Eloy JO; Department of Pharmacy, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza - CE, Brazil. Electronic address: josimar.eloy@ufc.br.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Aug 15; Vol. 661, pp. 124439. Date of Electronic Publication: 2024 Jul 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: ErbB Receptors*/immunology , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/pathology , Liposomes* , Taxoids*/administration & dosage , Taxoids*/pharmacokinetics , Taxoids*/pharmacology , Taxoids*/chemistry , Xenograft Model Antitumor Assays* , Cetuximab*/administration & dosage , Drug Liberation*, Male ; Animals ; Humans ; Cell Line, Tumor ; Mice ; Mice, Nude ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Agents/chemistry ; Polyethylene Glycols/chemistry ; Polyethylene Glycols/administration & dosage ; Particle Size ; Drug Delivery Systems

المؤلفون: Joshi A; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India., Ghosh A; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India., Rai P; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India., Tilwani S; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India., Ramachandran V; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, 400012, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, Maharashtra, 400094, India., Amin M; Department of Pathology and Laboratory Medicine, University of Tennessee Health Science, Memphis, TN, USA., Kumar P; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India. prashant.kumar@karkinos.in.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India. prashant.kumar@karkinos.in.; Centre of Excellence for Cancer-Gangwal School of Medical Sciences and Technology, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India. prashant.kumar@karkinos.in.

المصدر: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Aug 06; Vol. 41 (9), pp. 219. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Drug Resistance, Neoplasm*/drug effects , Cisplatin*/pharmacology , Cisplatin*/therapeutic use , Taxoids*/pharmacology , Taxoids*/therapeutic use , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use, Humans ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Movement/drug effects

المؤلفون: Sarwar S; Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA., Morozov VM; Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA., Newcomb MA; Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA., Yan B; Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL, USA., Brant JO; Department of Biostatistics, University of Florida College of Medicine, Gainesville, FL, USA.; University of Florida Health Cancer Center, Gainesville, FL, USA., Opavsky R; Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA.; University of Florida Health Cancer Center, Gainesville, FL, USA., Guryanova OA; Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL, USA.; University of Florida Health Cancer Center, Gainesville, FL, USA., Ishov AM; Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA. ishov@ufl.edu.; University of Florida Health Cancer Center, Gainesville, FL, USA. ishov@ufl.edu.

المصدر: Cell death & disease [Cell Death Dis] 2024 Aug 01; Vol. 15 (8), pp. 558. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/metabolism , Prostatic Neoplasms, Castration-Resistant*/genetics , Drug Resistance, Neoplasm*/drug effects , ATP Binding Cassette Transporter, Subfamily B*/metabolism , ATP Binding Cassette Transporter, Subfamily B*/genetics , Docetaxel*/pharmacology , Drug Resistance, Multiple*/drug effects , Taxoids*/pharmacology , Taxoids*/therapeutic use, Humans ; Male ; Cell Line, Tumor ; Antineoplastic Agents/pharmacology

المؤلفون: Pan L; University of Konstanz, Department of Chemistry, Konstanz, Germany. lu.pan@uni-konstanz.de., Schneider F; University of Konstanz, Department of Chemistry, Konstanz, Germany.; Scripps Research, La Jolla, CA, USA., Ottenbruch M; University of Konstanz, Department of Chemistry, Konstanz, Germany., Wiechert R; University of Konstanz, Department of Chemistry, Konstanz, Germany.; Department of Chemistry, Johannes Gutenberg-University, Mainz, Germany., List T; University of Konstanz, Department of Chemistry, Konstanz, Germany., Schoch P; University of Konstanz, Department of Chemistry, Konstanz, Germany., Mertes B; University of Konstanz, Department of Chemistry, Konstanz, Germany., Gaich T; University of Konstanz, Department of Chemistry, Konstanz, Germany. tanja.gaich@uni-konstanz.de.

المصدر: Nature [Nature] 2024 Aug; Vol. 632 (8025), pp. 543-549. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: Bridged-Ring Compounds*/chemical synthesis , Bridged-Ring Compounds*/chemistry , Chemistry Techniques, Synthetic* , Diterpenes*/chemical synthesis , Diterpenes*/chemistry , Taxoids*/chemistry , Taxoids*/chemical synthesis, Biological Products/chemical synthesis ; Biological Products/chemistry ; Carbon/chemistry ; Stereoisomerism ; Paclitaxel/chemistry

المؤلفون: Agema BC; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: b.agema@erasmusmc.nl., Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Viskil M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., de Neijs MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Sassen SDT; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Koch BCP; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Joerger M; Department of Medical Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

المصدر: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 786-793. Date of Electronic Publication: 2023 Nov 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neutropenia*/chemically induced , Neutropenia*/blood , Taxoids*/adverse effects , Taxoids*/therapeutic use , Taxoids*/pharmacokinetics, Humans ; Male ; Middle Aged ; Aged ; Female ; Antineoplastic Agents/adverse effects ; Neutrophils/drug effects ; Adult ; Prostatic Neoplasms/drug therapy ; Leukocyte Count

المؤلفون: Jiang M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Chai Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Liu J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., He M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang Y; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yang X; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Xing Z; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhou S; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Ma F; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yuan P; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Xu B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. xubinghebm@163.com., Li Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. liqiao@cicams.ac.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Jul 22; Vol. 24 (1), pp. 877. Date of Electronic Publication: 2024 Jul 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Carboplatin*/administration & dosage , Carboplatin*/therapeutic use , Neoadjuvant Therapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Receptor, ErbB-2*/metabolism , Propensity Score* , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Taxoids*/administration & dosage , Taxoids*/therapeutic use, Humans ; Female ; Middle Aged ; Prospective Studies ; Adult ; Aged ; Trastuzumab/therapeutic use ; Trastuzumab/administration & dosage ; Treatment Outcome

المؤلفون: Küster JHS; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany., Erb HHH; Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Ahrend H; Department of Medicine, Israelite Hospital Hamburg, Hamburg, Germany., Abazid A; Department of General, Visceral and Thorax Surgery, Bundeswehr Hospital Berlin, Berlin, Germany., Stope MB; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany; matthias.stope@ukbonn.de.

المصدر: Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 2815-2821.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Taxoids*/pharmacology , Taxoids*/therapeutic use , Docetaxel*/pharmacology , Phenylthiohydantoin*/pharmacology , Phenylthiohydantoin*/analogs & derivatives , Phenylthiohydantoin*/therapeutic use , Benzamides* , Nitriles* , HSP27 Heat-Shock Proteins*/metabolism , Drug Resistance, Neoplasm*/drug effects , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/pathology , Androstenes*/pharmacology , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Cell Proliferation*/drug effects, Humans ; Male ; Cell Line, Tumor ; Molecular Chaperones/metabolism ; Heat-Shock Proteins/metabolism

المؤلفون: Bir Yücel K; Department of Medical Oncology, Gazi University, Ankara, Turkey., Uğraklı M; Department of Medical Oncology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey., Sekmek S; Department of Medical Oncology, Bilkent City Hospital, Ankara, Turkey., Yıldırım N; Department of Medical Oncology, Fırat University Faculty of Medicine, Elazığ, Turkey., Gürler F; Department of Medical Oncology, Gazi University, Ankara, Turkey., Yazıcı O; Department of Medical Oncology, Gazi University, Ankara, Turkey., Özet A; Department of Medical Oncology, Gazi University, Ankara, Turkey., Bal Ö; Department of Medical Oncology, Bilkent City Hospital, Ankara, Turkey., Araz M; Department of Medical Oncology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey., Artaç M; Department of Medical Oncology, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey., Özdemir N; Department of Medical Oncology, Gazi University, Ankara, Turkey.

المصدر: Current medical research and opinion [Curr Med Res Opin] 2024 Jul; Vol. 40 (7), pp. 1137-1143. Date of Electronic Publication: 2024 Jun 22.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Stomach Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Taxoids*/administration & dosage , Taxoids*/therapeutic use , Taxoids*/adverse effects , Fluorouracil*/administration & dosage , Fluorouracil*/therapeutic use , Fluorouracil*/adverse effects, Humans ; Middle Aged ; Female ; Male ; Adult ; Aged ; Turkey ; Young Adult ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Docetaxel/administration & dosage ; Docetaxel/therapeutic use ; Leucovorin/administration & dosage ; Leucovorin/therapeutic use ; Leucovorin/adverse effects ; Treatment Outcome ; Oxaliplatin/administration & dosage ; Oxaliplatin/adverse effects ; Oxaliplatin/therapeutic use ; Bridged-Ring Compounds/administration & dosage ; Bridged-Ring Compounds/therapeutic use ; Bridged-Ring Compounds/adverse effects ; Camptothecin/analogs & derivatives ; Camptothecin/administration & dosage ; Camptothecin/therapeutic use ; Camptothecin/adverse effects

SCR Protocol: IFL protocol